发明名称 COMBINED AGENT
摘要 PROBLEM TO BE SOLVED: To provide a medicine which can be widely applicable to diseases such as thamuria, incontinence, asthma, chronic obstructive pulmonary disease, rheumatoid arthritis, osteoarthritis, dolor, cough, hypersensitivity enteropathy, vomiting, depression, anxiety, manic-depressive psychosis and schizophrenia. SOLUTION: The medicine comprises a combination of an NK-1 receptor antagonist, an NK-2 receptor antagonist and/or an anticholinergic agent. The medicine is effective as a preventive or a curative for thamuria, incontinence, asthma, chronic obstructive pulmonary disease, rheumatoid arthritis, osteoarthritis, dolor, cough, hypersensitivity enteropathy, vomiting, depression, anxiety, manic-depressive psychosis and schizophrenia. In particular, the medicine comprises a combination of a compound represented by formula (1) [wherein, each symbol in the formula is defined in the description], its salt or its prodrug, an NK-2 receptor antagonist, and/or an anticholinergic agent.
申请公布号 JP2002249432(A) 申请公布日期 2002.09.06
申请号 JP20010390486 申请日期 2001.12.21
申请人 TAKEDA CHEM IND LTD 发明人 DOI TAKAYUKI;HASHIMOTO TADATOSHI;KAMO IZUMI
分类号 C07D471/14;A61K31/216;A61K31/4353;A61K31/4375;A61K31/551;A61K45/00;A61K45/06;A61P1/06;A61P1/08;A61P7/12;A61P11/00;A61P11/06;A61P11/14;A61P19/02;A61P25/04;A61P25/18;A61P25/22;A61P25/24;A61P29/00;A61P43/00;(IPC1-7):A61K31/435;A61K31/437 主分类号 C07D471/14
代理机构 代理人
主权项
地址